Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alimera Files MAA For Iluvien To MHRA In UK
Iluvien is a sustained release drug delivery system that release steroid flucocinolone acetonide for the treatment of diabetic macular edema (DME). A 24 month low dose data from
Iluvien is a sustained release drug delivery system that release steroid flucocinolone acetonide for the treatment of diabetic macular edema (DME). A 24 month low dose data from
Following consumer complaints of a musty or moldy odor, which has been linked to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole (TBA), McNeil recalled the
Anastrozole is an aromatase inhibitor, which interrupts a critical step in the body’s synthesis of estrogen. Some breast cancer cells require estrogen to grow, and eliminating estrogen suppresses
Cempra Pharma paid the milestone following the development of macrolide (CEM-101) for the treatment of respiratory infections. Cempra Pharma has licensed CEM-101 from Optimer Pharma and has completed
As per the agreement, Amerinet members will have immediate purchasing/leasing access to Sysmex automated urine particle analyzers, reagents, controls, and service. Headquartered in Mundelein, Illinois, Sysmex America provides
Prior to joining Amneal Pharma Dr Hariharan worked as CSO and EVP of Par Pharmaceutical. Additionally, he built internal expertise in abbreviated new drug applications (ANDAs) for generics
With this expansion Waltrop capabilities are extended through the addition of solid and semi-solid production to its hormone facility (operational since August 2005) with production areas, separate personnel
According to Roche, in the trial, 1 in 10 women age 30-years and older, who tested positive for HPV genotypes 16 and/or 18 by the cobas 4800 HPV
The LightCycler MRSA Advanced Test is a qualitative in-vitro diagnostic test for the direct detection of nasal colonization with bacterial MRSA, and is designed to aid in the
TB-402 Phase II trial data was presented at the 21st International Congress on Thrombosis (ICT) in Milan, Italy by Peter Verhamme of University of Leuven, Belgium, in a